Accumulation of toxic α-synuclein oligomer within endoplasmic reticulum occurs in α-synucleinopathy in vivo

Emanuela Colla, Poul H. Jensen, Olga Pletnikova, Juan C Troncoso, Charles Glabe, Michael K. Lee

Research output: Contribution to journalArticle

Abstract

In Parkinson's disease (PD) and other α-synucleinopathies, prefibrillar α-synuclein (αS) oligomer is implicated in the pathogenesis. However, toxic αS oligomers observed using in vitro systems are not generally seen to be associated with α-synucleinopathy in vivo. Thus, the pathologic significance of αS oligomers to αS neurotoxicity is unknown. Herein, we show that, αS that accumulate within endoplasmic reticulum (ER)/microsome forms toxic oligomers in mouse and human brain with the α-synucleinopathy. In the mouse model of α-synucleinopathy, αS oligomers initially form before the onset of disease and continue to accumulate with the disease progression. Significantly, treatment of αS transgenic mice with Salubrinal, an anti-ER stress compound that delays the onset of disease, reduces ER accumulation of αS oligomers. These results indicate that αS oligomers with toxic conformation accumulate in ER, and αS oligomerdependent ER stress is pathologically relevant for PD.

Original languageEnglish (US)
Pages (from-to)3301-3305
Number of pages5
JournalJournal of Neuroscience
Volume32
Issue number10
DOIs
StatePublished - Mar 7 2012

Fingerprint

Synucleins
Poisons
Endoplasmic Reticulum
Endoplasmic Reticulum Stress
Parkinson Disease
Microsomes
Transgenic Mice
Disease Progression
Brain

ASJC Scopus subject areas

  • Neuroscience(all)

Cite this

Accumulation of toxic α-synuclein oligomer within endoplasmic reticulum occurs in α-synucleinopathy in vivo. / Colla, Emanuela; Jensen, Poul H.; Pletnikova, Olga; Troncoso, Juan C; Glabe, Charles; Lee, Michael K.

In: Journal of Neuroscience, Vol. 32, No. 10, 07.03.2012, p. 3301-3305.

Research output: Contribution to journalArticle

Colla, Emanuela ; Jensen, Poul H. ; Pletnikova, Olga ; Troncoso, Juan C ; Glabe, Charles ; Lee, Michael K. / Accumulation of toxic α-synuclein oligomer within endoplasmic reticulum occurs in α-synucleinopathy in vivo. In: Journal of Neuroscience. 2012 ; Vol. 32, No. 10. pp. 3301-3305.
@article{f6bfa3ea8c7c4a448a3d83333a564566,
title = "Accumulation of toxic α-synuclein oligomer within endoplasmic reticulum occurs in α-synucleinopathy in vivo",
abstract = "In Parkinson's disease (PD) and other α-synucleinopathies, prefibrillar α-synuclein (αS) oligomer is implicated in the pathogenesis. However, toxic αS oligomers observed using in vitro systems are not generally seen to be associated with α-synucleinopathy in vivo. Thus, the pathologic significance of αS oligomers to αS neurotoxicity is unknown. Herein, we show that, αS that accumulate within endoplasmic reticulum (ER)/microsome forms toxic oligomers in mouse and human brain with the α-synucleinopathy. In the mouse model of α-synucleinopathy, αS oligomers initially form before the onset of disease and continue to accumulate with the disease progression. Significantly, treatment of αS transgenic mice with Salubrinal, an anti-ER stress compound that delays the onset of disease, reduces ER accumulation of αS oligomers. These results indicate that αS oligomers with toxic conformation accumulate in ER, and αS oligomerdependent ER stress is pathologically relevant for PD.",
author = "Emanuela Colla and Jensen, {Poul H.} and Olga Pletnikova and Troncoso, {Juan C} and Charles Glabe and Lee, {Michael K.}",
year = "2012",
month = "3",
day = "7",
doi = "10.1523/JNEUROSCI.5368-11.2012",
language = "English (US)",
volume = "32",
pages = "3301--3305",
journal = "Journal of Neuroscience",
issn = "0270-6474",
publisher = "Society for Neuroscience",
number = "10",

}

TY - JOUR

T1 - Accumulation of toxic α-synuclein oligomer within endoplasmic reticulum occurs in α-synucleinopathy in vivo

AU - Colla, Emanuela

AU - Jensen, Poul H.

AU - Pletnikova, Olga

AU - Troncoso, Juan C

AU - Glabe, Charles

AU - Lee, Michael K.

PY - 2012/3/7

Y1 - 2012/3/7

N2 - In Parkinson's disease (PD) and other α-synucleinopathies, prefibrillar α-synuclein (αS) oligomer is implicated in the pathogenesis. However, toxic αS oligomers observed using in vitro systems are not generally seen to be associated with α-synucleinopathy in vivo. Thus, the pathologic significance of αS oligomers to αS neurotoxicity is unknown. Herein, we show that, αS that accumulate within endoplasmic reticulum (ER)/microsome forms toxic oligomers in mouse and human brain with the α-synucleinopathy. In the mouse model of α-synucleinopathy, αS oligomers initially form before the onset of disease and continue to accumulate with the disease progression. Significantly, treatment of αS transgenic mice with Salubrinal, an anti-ER stress compound that delays the onset of disease, reduces ER accumulation of αS oligomers. These results indicate that αS oligomers with toxic conformation accumulate in ER, and αS oligomerdependent ER stress is pathologically relevant for PD.

AB - In Parkinson's disease (PD) and other α-synucleinopathies, prefibrillar α-synuclein (αS) oligomer is implicated in the pathogenesis. However, toxic αS oligomers observed using in vitro systems are not generally seen to be associated with α-synucleinopathy in vivo. Thus, the pathologic significance of αS oligomers to αS neurotoxicity is unknown. Herein, we show that, αS that accumulate within endoplasmic reticulum (ER)/microsome forms toxic oligomers in mouse and human brain with the α-synucleinopathy. In the mouse model of α-synucleinopathy, αS oligomers initially form before the onset of disease and continue to accumulate with the disease progression. Significantly, treatment of αS transgenic mice with Salubrinal, an anti-ER stress compound that delays the onset of disease, reduces ER accumulation of αS oligomers. These results indicate that αS oligomers with toxic conformation accumulate in ER, and αS oligomerdependent ER stress is pathologically relevant for PD.

UR - http://www.scopus.com/inward/record.url?scp=84863229691&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84863229691&partnerID=8YFLogxK

U2 - 10.1523/JNEUROSCI.5368-11.2012

DO - 10.1523/JNEUROSCI.5368-11.2012

M3 - Article

VL - 32

SP - 3301

EP - 3305

JO - Journal of Neuroscience

JF - Journal of Neuroscience

SN - 0270-6474

IS - 10

ER -